Cargando…
Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer
Lung cancer is one of the most common malignant tumours worldwide, with the highest mortality rate. Approximately 1.6 million deaths owing to lung cancer are reported annually; of which, 85% of deaths occur owing to non-small-cell lung cancer (NSCLC). At present, the conventional treatment methods f...
Autores principales: | Yang, Yu-Chen, Zhao, Can-Jun, Jin, Zhao-Feng, Zheng, Jin, Ma, Li-Tian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036052/ https://www.ncbi.nlm.nih.gov/pubmed/36969062 http://dx.doi.org/10.3389/fonc.2023.1120828 |
Ejemplares similares
-
CRL Ubiquitin Ligases and DNA Damage Response
por: Li, Ju-Mei, et al.
Publicado: (2012) -
Ubiquitin ligase RNF125 targets PD-L1 for ubiquitination and degradation
por: Wei, Meng, et al.
Publicado: (2022) -
E3 ubiquitin ligases in the acute leukemic signaling pathways
por: Zhan, Qianru, et al.
Publicado: (2022) -
Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer
por: Sun, Aiqin, et al.
Publicado: (2023) -
Role of ubiquitin specific proteases in the immune microenvironment of prostate cancer: A new direction
por: Guo, Jinhui, et al.
Publicado: (2022)